Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Pharma unprepared for shift to secondary care

November 28, 2005 Research and Development

Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …
News

New antibody could be COPD breakthrough, say companies

November 21, 2005 Research and Development Argenta, COPD, Domantis

 Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
News

Oxford and GSK to collaborate on cancer research in India

November 18, 2005 Research and Development

The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …
News

Study results not IDEAL for Lipitor

November 16, 2005 Research and Development, Sales and Marketing

A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …
News

Enhancing the drug development process

November 9, 2005 Research and Development

MEDICAL SOLUTIONS SPONSORED FEATURERecently, we have seen a massive increase in our knowledge and understanding of the biochemical mechanisms that, …
Feature

US acquisitions a coup for Cambridge Antibody

November 8, 2005 Research and Development

Cambridge Antibody Technology has bought two promising oncology candidates from US biotech company Genencor, and has established its first research …
News

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005 Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
News

GSK inspires more confidence than shaky AstraZeneca

November 1, 2005 Research and Development

The UK's two pharma giants have posted strong growth in the third quarter, but investor doubts about AstraZeneca's long-term prospects …
News

Tropical disease research centre to open in Liverpool

October 31, 2005 Research and Development

A new UK research centre specialising in the development of new tropical medicines has been given the go-ahead with £18 …
News

Campaigners dismayed at unworkable partial smoking ban

October 28, 2005 Research and Development

Doctors and health campaigners have expressed their deep disappointment over the government's failure to introduce a complete smoking ban in …
News

Oxford BioMedica’s lung cancer candidate shows promise

October 25, 2005 Research and Development

A promising antibody developed by UK-based Oxford BioMedica is poised to enter clinical trials to treat lung cancer.The 5T4 antibody-targeted …
News

Blockbuster partnerships

October 21, 2005 Research and Development

Since pharma'ps big wave of innovation during the early 1990s, peaking in 1996 when 131 new drug applications were filed …
Feature

Merck to co-develop novel prostate cancer candidate

October 18, 2005 Research and Development

Merck is to develop a new monoclonal antibody which has shown promise in treating prostate cancer.The US company has signed …
News

Winning CROs look east for expansion

October 18, 2005 Research and Development

The new onus on outsourcing has seen CROs reap the benefits of an industry striving to cut resource investment while …
Feature

Genzyme opens first European research centre in Cambridge

September 30, 2005 Research and Development

Genzyme, one of the most successful US biotech companies, has opened its first European research centre in Cambridge, UK – …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025